| Product Code: ETC9698721 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand mRNA Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand mRNA Therapeutics Market - Industry Life Cycle |
3.4 Thailand mRNA Therapeutics Market - Porter's Five Forces |
3.5 Thailand mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Thailand mRNA Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be targeted by mRNA therapeutics in Thailand |
4.2.2 Growing investments in research and development of mRNA therapeutics in the country |
4.2.3 Favorable regulatory environment supporting the development and commercialization of mRNA therapeutics in Thailand |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA therapeutics development and production |
4.3.2 Limited awareness and acceptance of mRNA therapeutics among healthcare professionals and patients in Thailand |
4.3.3 Challenges in scaling up production and distribution of mRNA therapeutics in the country |
5 Thailand mRNA Therapeutics Market Trends |
6 Thailand mRNA Therapeutics Market, By Types |
6.1 Thailand mRNA Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F |
6.1.4 Thailand mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2 Thailand mRNA Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Thailand mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Thailand mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F |
6.2.5 Thailand mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.6 Thailand mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand mRNA Therapeutics Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Thailand mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Thailand mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.4 Thailand mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand mRNA Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand mRNA Therapeutics Market Export to Major Countries |
7.2 Thailand mRNA Therapeutics Market Imports from Major Countries |
8 Thailand mRNA Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials for mRNA therapeutics conducted in Thailand |
8.2 Percentage increase in funding for mRNA therapeutics research and development in the country |
8.3 Adoption rate of mRNA therapeutics by healthcare facilities and practitioners in Thailand |
8.4 Number of partnerships and collaborations between local and international companies in the mRNA therapeutics sector in Thailand |
9 Thailand mRNA Therapeutics Market - Opportunity Assessment |
9.1 Thailand mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Thailand mRNA Therapeutics Market - Competitive Landscape |
10.1 Thailand mRNA Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here